146 related articles for article (PubMed ID: 38429534)
1. COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway.
Hu J; Li P; Dan Y; Chen Z; Lu Y; Chen X; Yan S
Ann Surg Oncol; 2024 May; 31(5):3502-3512. PubMed ID: 38429534
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
Liang W; Wang C; Wang J; Zhang M
Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
[TBL] [Abstract][Full Text] [Related]
5. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
Zhang J; Kong R; Sun L
Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755
[TBL] [Abstract][Full Text] [Related]
7. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
8. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
9. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
10. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
[TBL] [Abstract][Full Text] [Related]
11. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract][Full Text] [Related]
12. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
Liang Y; Li S
Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
[TBL] [Abstract][Full Text] [Related]
13. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
[TBL] [Abstract][Full Text] [Related]
14. AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway.
Li X; Dong H; Zheng Y; Ding S; Li Y; Li H; Huang H; Zhong C; Xie T; Xu Y
Mol Cell Probes; 2023 Dec; 72():101939. PubMed ID: 37879503
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
[TBL] [Abstract][Full Text] [Related]
16. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
[TBL] [Abstract][Full Text] [Related]
17. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
[TBL] [Abstract][Full Text] [Related]
18. Dandelion root extract affects ESCC progression
Duan X; Pan L; Deng Y; Liu Y; Han X; Fu H; Li Y; Li M; Wang T
Food Funct; 2021 Oct; 12(19):9486-9502. PubMed ID: 34476429
[TBL] [Abstract][Full Text] [Related]
19. E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375.
Li P; Lv H; Wu Y; Xu K; Xu M; Ma Y
Bioengineered; 2021 Dec; 12(2):10047-10062. PubMed ID: 34699320
[TBL] [Abstract][Full Text] [Related]
20. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
